Serial 98404547

Live / Registered — Registered (as of 20 Jan 2026)

What this means for you

Registered since 20 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98404547
Registration number
8106108
Mark type
Design / logo
Filed
13 Feb 2024
Published for opposition
02 Dec 2025
Registered
20 Jan 2026
Attorney of record
Eric Lamb

Goods and services

  • Class 001 — Chemicals: Chemical products and proteins both for use in the manufacture of industrial chemicals and biological pharmaceutical products; chemical products being industrial chemicals and protein in raw material form for scientific and medical research being research of chemical and biological pharmaceutical products; chemical products being industrial chemicals and proteins for industrial use in the field of diagnostic use, except medical or veterinary uses; protein for industrial use and G-protein coupled receptors being protein for industrial use for manufacturing pharmaceutical products; protein for industrial use and G-protein-coupled receptors being protein for industrial use for the research of pharmaceutical products; industrial chemicals and protein for industrial use for use in the fields of chemical and biological drug discovery, lead identification and diagnostics; protein for industrial use and G-protein-coupled receptors being protein for industrial use for drug discovery purposes; industrial chemicals and biologicals in the nature of protein for industrial use, transmembrane proteins and G-proteins both being protein for industrial use, G-protein-coupled receptors being protein for industrial use, and fragments thereof being sequences of amino acids in the nature of amino acids, other than for medical or veterinary purposes, for use in the fields of chemical and biological drug discovery, lead identification and diagnostics; protein for industrial use in the nature of transmembrane proteins and G-proteins both being protein for industrial use, G-protein-coupled receptors being protein for industrial use, and fragments thereof being sequences of amino acids in the nature of amino acids, other than for medical or veterinary purposes, for use in the fields of pharmaceutical research and drug discovery purposes
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; medicines for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; biological products for medical purposes, namely, medicinal preparations being G-protein-coupled receptors for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders for use in the fields of chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, protein supplements; biological and chemical products for medical use, namely, medicinal preparation being G-protein-coupled receptors for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; biological and chemical products for medical use, namely, medicinal preparation being transmembrane proteins for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; biological and chemical products for medical use, namely, medicinal preparation being G-proteins for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; biological and chemical products for medical use, namely, antibodies for medical purposes and synthetic peptides and parts thereof being synthetic peptides for therapeutic purposes for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; chemical reagents for medical use and protein supplements for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders for use in the field of medical diagnostics; biological products being medicinal preparations for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders for use in the field of chemical and biological drug discovery, and in the field of lead identification and diagnostics; biological products being medicinal preparations for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders for therapeutic purposes; biological formulation being medicinal preparations for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders for use in the field of developing chemical and biological pharmaceutical products; biological formulation being medicinal preparations for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders for use in the field of identifying lead chemical and biological products; biological formulation being medicinal preparations for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders for diagnostic use; biological formulation being medicinal preparations for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders for therapeutic use; protein supplements and medicinal preparations being G-protein-coupled receptors, both for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders for use in the field of drug discovery purposes; biological reagents for medical purposes and medicinal preparations being small chemical entities for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; medicinal preparations being G-protein-coupled receptors for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; medicinal preparations being transmembrane proteins for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; medicinal preparations being G-proteins for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; antibodies for medical purposes and synthetic peptides for therapeutic purposes for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; protein supplements for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders; antibodies for medical purposes and synthetic peptides for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing G-protein-coupled receptor-mediated and G-protein-coupled receptor-implicated diseases and disorders in the field of medical diagnostics
  • Class 035 — Advertising and business services: Business management, business organization consulting, and business administration, all provided in the fields of chemical products, biological products, pharmaceuticals, design and development of drugs, and drug discovery; Business management, business organization consulting, and business administration, all provided in the field of pharmaceutical and biopharmaceutical research and development, and field of technologies related to proteins and G-protein-coupled receptors; wholesale and retail store services featuring pharmaceuticals, biological products and chemical and biological preparations
  • Class 042 — Scientific and technological services: Drug discovery services and pharmaceutical discovery services being pharmaceutical research services; Biotechnology research; pharmaceutical research services; chemical and medical testing in the nature of testing of chemicals; research, development, advice, consultancy and information services, namely, design and testing of new products for others; research and development services in the field of pharmaceutical preparations being pharmaceuticals and biopharmaceuticals and field of pharmaceutical preparations being technologies related to proteins and G-protein-coupled receptors; pharmaceutical research services in the fields of chemical and biological drug discovery and development; pharmaceutical research services and pharmaceutical products development for identifying lead chemical compounds; examination and research services being pharmaceutical research services in the field of medicinal and synthetic chemistry; scientific research and development services in the fields of creation of libraries and collections of biologicals, chemicals and compounds; research, creation, and development, namely, scientific research and development in the field of chemical and biological drug targets for screening purposes; research, analysis and examination, namely, scientific research and development in the field of identification of compounds through automated screening processes; scientific research and development services in the field of chemical and biological pharmaceutical development; medical research laboratory services; provision of information, advisory services and consultancy in connection with all of the aforesaid services
  • Class 044 — Medical, beauty and agricultural services: Pharmaceutical compounding services; pharmaceutical advice and medical and pharmaceutical consultation; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical and pharmaceutical consultation in the fields of research, creation, development and provision of chemical and biological drug targets for medical screening purposes; all of the aforesaid services provided in the field of drug discovery and field of use of G-protein- coupled receptors in the design and development of pharmaceutical products

Owner

Prosecution history

  • 20 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 20 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
  • 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 02 Dec 2025 — PUBLISHED FOR OPPOSITION
  • 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 31 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 31 Oct 2025 — EXAMINER'S AMENDMENT ENTERED
  • 31 Oct 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 31 Oct 2025 — EXAMINERS AMENDMENT E-MAILED
  • 31 Oct 2025 — EXAMINERS AMENDMENT -WRITTEN
  • 23 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 23 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 23 Jul 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
  • 25 Jun 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 25 Jun 2025 — FINAL REFUSAL E-MAILED

View this trademark record on Marksy